Mujer de 17 años con fiebre y adenopatías cervicales

Medicina Clinica

Volumn 112, Issue 11, 1999, Pages 428-435

  Oristrell, Joaquim ^a   Miquel, Rosa ^b  

^a Servicio de Oncología Médica   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BIOPSY; CASE REPORT; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; KIKUCHI DISEASE; LYMPH NODE; NECK; PATHOLOGY;

ADOLESCENT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS; LYMPH NODES; NECK;

EID: 0033608635     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Carithers HA. Cat-scratch disease: an overview based on a study of 1,200 patients. Am J Dis Child 1985; 139: 1.124-1.133.
2. Zangwill KM, Hamilton DH, Perkins BA, Regnery RL, Plikaytis BD, Hadler JL et al. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med 1993; 329: 8-13.
3. Álvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston city and other hospitals. Medicine (Baltimore) 1984; 63: 25-55.
4. Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21: 283-290.
5. Colmenero JD, Reguera JM, Martos F, Sánchez-de-Mora D, Delgado M, Causse M et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75: 195-211.
6. Ereno C, López JI, Elizalde JM, Ibañez T, Fernández Larrinoa A, Toledo JD. A case of Whipple's disease presenting as supraclavicular lymphadenopathy. A case report. APMIS 1993; 101: 865-868.
7. Olansky S. Treponematosis. En: Sanford JP, Luby JP, editores. Infectious Diseases. Nueva York: Grune Stratton Inc., 1981; 298-305.
8. a ed.). Madrid: Editorial Médica Panamericana, 1997; 1.528-1.544.
9. Christmann P, Hansmann Y. Mononucléose infectieuse. Rev Prat 1997; 47: 1.037-1.039.
10. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 1995; 84: 1.271-1.275.
11. Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour Jr HH et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Medicine (Baltimore) 1986; 65: 124-134.
12. Vanhems P, Allard R, Cooper DA, Perrin L, Vizzard J, Hirschel B et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24: 965-970.
13. McCabe RE, Brooks RG, Dorfman RF, Remington JS. Clinical spectrum in 107 cases of toxoplasmic lymphadenitis. Rev Infect Dis 1987; 9: 754-774.
14. Montoya JG, Remington JS. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis 1995; 20: 781-789.
15. Segal GH, Clough D, Tubbs RR. Autoimmune and iatrogenic causes of lymphadenopathy. Semin Oncol 1993; 20: 611-626.
16. Arnett FC, Edworthy SM, Bloch DA, McShame DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
17. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1.271-1.277.
18. Vitali C, Bombardieri S, Moutsopoulos HM. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-347.
19. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwazaki S et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424-430.
20. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1.078-1.080.
21. Rowley AH, González-Crussi F, Shulman ST. Kawasaki syndrome. Rev Infect Dis 1988; 10: 1-15.
22. Semenzato G, Agostini C, Chilosi M. Immunology and immunopathology. En: James G, editor. Sarcoidosis and granulomatous disorders. Nueva York: Marcel Dekker, Inc. 1994; 153-179.
23. Badrinas F. Estado actual del diagnostico y criterios de actividad de la sarcoidosis. MTA Medicina Interna 1983; 1: 197-251.
24. Quiroga Prado L, Díaz Sánchez J, Navia-Osorio JM, Cartón Sánchez JA, Vallina Alvarez E, Arribas Castrillo JM. Poblaciones linfocitarias en sangre periférica en la sarcoidosis. An Med Intern (Madr) 1984; 4: 121-126.
25. Drenth JPH, Haagsma CJ, Van der Meer JWM, and the international hyper-lgD study group. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. Medicine (Baltimore) 1994; 73: 133-144.
26. Drenth JPH, Denecker NEJ, Prieur AM, Van der Meer JWM. Le syndrome hyper-immunoglobuline D. Presse Med 1995; 24: 1.211-1.213.
27. Schibler A, Birrer P, Vella S. PFAPA-syndrome: periodisches Fieber, Adenitis, Pharyngitis und aphtöse Stomatitis. Schweiz Med Wochenschr 1997; 127: 1.280-1.284.
28. Majeed HA, Barakat M. Familial mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases. Eur J Pediatr 1989; 148: 636-641.
29. Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Clinical approach to lymphadenopathy. Semin Oncol 1993; 20: 570-582.
30. Rozman C, Bosch F, Montserrat E. Chronic lymphocytic leukemia: a changing natural history? Leukemia 1997; 11: 775-778.
31. Mauch PM, Kalish LA, Kadin MC, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin's disease: implications for etiology and pathogenesis. Cancer 1993; 71: 2.062-2.071.
32. Ben-Ezra J, Burke JS, Swartz WG, Brownell MD, Brynes RK, Hill LR et al. Small lyrnphocytic lymphoma: a clinicopathological analysis of 268 cases. Blood 1989; 73: 579-587.
33. Obeso G, Rivas C, Blanco I, Marcos B, García Delgado R, Echezarreta G et al. Linfoma del manto folicular: estudio clinicopatológico y proliferativo de 11 casos. Med Clin (Barc) 1993; 101: 406-409.
34. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer 1982; 49: 1.429-1.438.
35. Wright D, McKeever P, Carter RTI. Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group. J Clin Pathol 1997; 50: 128-134.
36. Nathwani BN, Diamond LW, Winberg CD, Kim H, Bearman RM, Glick JH et al. Lymphoblastic lymphoma. A clinicopathologic study of 95 patients. Cancer 1981; 48: 2.347-2.357.
37. Grupo español para el estudio del HTLV-I/II. HTLV-I γ HTLV-II en España. An Med Intern (Madr) 1995; 12: 299-306.
38. Andrès P, Lepagney ML, Bureau B, Litoux P, Dréno B. Primary cutaneous lymphomas: a study of 37 cases. Int J Dermatol 1997; 36: 582-586.
39. Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3.727-3.734.
40. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305-316.
41. Freter CE, Cossman J. Angioimmunoblastic lymphadenopathy with dysproteinemia. Semin Oncol 1993; 20: 627-635.
42. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993; 20: 636-647.
43. Cline MJ. Histiocytes and histiocytosis. Blood 1994; 84: 2.840-2.853.
44. Favara BE. Langerhans' cell histiocytosis. Pathobiology and pathogenesis. Semin Oncol 1991; 18:3-7.
45. Chan JKC, Tsang WYW. Uncommon syndromes of reactive lymphadenopathy. Semin Oncol 1993; 20:648-657.
46. Dorfman RF, Berry GJ. Kikuchi's histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis. Semin Diagn Pathol 1988; 5: 329-345.
47. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi 1972, 35: 379-380.
48. Fujimoto Y, Kozima Y, Yasmaguchi K. Cervical subacute necrotizing lymphadenitis: a new clinicopathological entity. Naika 1972; 20: 920-927.
49. Rozman C, Moragas A. Linfadenitis necrotizante de Kikuchi, una nueva entidad clinico-patológica. Med Clin (Barc) 1985; 85: 670-672.
50. Rodríguez JN, Aguado M, Elizalde J, Martino ML, Moreno MV, Lara C et al. Enfermedad de Kikuchi-Fujimoto asociada a infección aguda por virus herpes 6. Sangre (Barc) 1986; 41: 387-390.
51. Vega M, Fresno MF, Pérez del Rio MJ, Triviño A, Riera JR, Herrero A. Linfadenitis necrotizante no granulocitica (enfermedad de Kikuchi). Patología 1996; 29: 295-302.
52. Zabaleta M, Mollá FJ, Martínez Torre MI, Sánchez L, Erdozain I. Enfermedad de Kikuchi. Acta Otorrinolaring Esp 1997; 48: 322-324.
53. Kikuchi M, Takeshita M, Eimoto T, Iwasaki H, Minamishima Y, Maeda Y. Histiocytic necrotizing lymphadenitis: clinicopathologic, immunologic, and HLA typing study. En: Hanaoka M, Kadin ME, Mikata A, editores. Lymphoid malignancy: immunocytology and cytogenetics. Nueva York: Fields and Wood, 1990; 251-257.
54. Tsang WYW, Chan J.K.C., Ng C.S. Kikuchi's Lymphadenitis. Am J Surg Path 1994; 18: 219-231.
55. Kuo T. Kikuchi's disease (Histiocytic necrotizing lymphadenitis). Am J Surg Pathol 1995; 19: 798-809.
56. Asano S, Akaike Y, Muramatsu T, Wakasa H, Yoshida H, Kondow R et al. Necrotizing lymphadenitis: a clinicopathological and immunohistochemical study of four familial cases and five recurrent cases. Virchows Arch (A) 1991; 418: 215-223.
57. Chan JKC, Wong KC, Ng CS. A fatal case of multicentric Kikuchi's histiocytic necrotizing lymphadenitis. Cancer 1989; 63: 1.856-1.862.
58. Yen A, Fearneyhough P, Raimer SS, Hudnall SD. EBV-associated Kikuchi's histiocytic necrotizing lymphadenitis with cutaneous manifestations. J Am Acad Dermatol 1997; 36: 342-346.
59. Chan JKC, Tsang WYW. Reactive Lymphadenopathies. En: Weiss LM, editor Pathology of lymph nodes. Nueva York: Churchill Livingstone, 1996; 106-110.
60. Schnitzer B. Reactive lymphoid hyperplasias. En: Jaffe ES, editor. Surgical Pathology of the lymph nodes and related organs. Filadelfia: Saunders, 1995; 124-125.
61. Sumihoshi Y, Kikuchi M, Takeshita M, Ohshima K, Masuda Y, Parwaewsh MR. Immunohistologic studies of Kikuchi's disease. Hum Pathol 1993; 24: 1.114-1.119.
62. Litwin MD, Kirkham B, Henderson DRF, Milazzo SC. Histiocytic necrotizing lymphadenitis in systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 805-807.
63. Davies CWH, Wathen CG. Kikuchi's disease and systemic lupus erythematosus. Respir Med 1997; 91: 117-119.
64. Kikuchi M, Yoshizumi T, Nakamura H. Necrotizing lymphadenitis: possible acute toxoplasmic infection. Virchows Arch A Pathol Anat Histol 1977; 37: 247-253.
65. Rodríguez MJ, Martin MV, Baez JM, Gil JL. Linfadenitis necrosante de Kikuchi Mijimoto asociada a brucelosis. Sangre (Barc) 1992; 37: 201-204.
66. Feller AC, Lennert K, Stein H, Bruhn HD, Euthe HH. Immunohistology and aetiology of histiocytic necrotizing lymphadenitis. Report of three instructive cases. Histopathology 1983; 7: 825-839.
67. Yufu Y, Matsumoto M, Miyamura T, Nishimura J, Nawata H, Ohshima K. Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease). Br J Haematol 1997; 96: 868-871.
68. Bataille V, Harland CC, Behrens J, Cook MG, Holden CA. Kikuchi disease (histiocytic necrotizing lymphadenitis) in association with HTLV1. Br J Dermatol 1997; 136: 610-612.
69. Pileri SA, Sabattini E, Costigliola P, Poggi S, Ricchi E, Tumietto F et al. Kikuchi's lymphadenitis and HIV infection. AIDS 1991; 5: 459-461.
70. Sumiyoshi Y, Kikuchi M, Minematu T, Ohshima K, Takeshita M, Minamishima Y. Analysis of herpesvirus genomes in Kikuchi's disease. Virchow Archiv 1994; 424: 437-440.
71. Sumiyoshi Y, Kikuchi M, Ohshima K, Yoneda S, Kobari S, Takeshita M et al. Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi's disease) and other forms of lymphadenitis. Am J Clin Pathol 1993; 99: 609-614.
72. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67: 5-23.
73. Agnastapoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr. Blood 1995; 85: 744-750.
74. Weiss LM, Chen YY, Liu X, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1.259-1.265.
75. Jaffe ES, Chan JK, Su IJ, Frizzeia G, Mori S, Feller AC et al. Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphomas: definitions, differential diagnosis and epidemiology. Am J Surg Pathol 1996; 20: 103-111.
76. Harris NL, Ferry JA, Swerdlow SH. Posttrasplant lymphoproliferative disorders: summary of Society for hematopathology workshop. Semin Diagn Pathol 1997; 14:8-14.
77. Chadburn A, Cesarman E, Knowles DM. Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol 1997; 14: 15-26.
78. Elenitoba-Johnson KSJ, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997; 14: 35-47.
79. Knowles DM. Molecular pathology of acquired immunodeficiency syndrome- related non-Hodgkin's lymphoma. Semin Diagn Pathol 1997; 14: 67-82.
80. Purtilo DT, Yang JPS, Cassel CK, Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's syndrome). Lancet 1975; 1: 935-940.
81. Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996; 87: 1.446-1.457.
82. Takakuwa T, Ohnuma S, Koike J, Hoshikawa M, Koizumi H. Involvement of cell mediated killing in apoptosis in histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). Histopathology 1996; 28: 41-48.
83. Teruya-Feldstein J, Jaffe ES, Burd PR, Kanegane H, Kingma DW, Wilson WH et al. The role of Mig, the monokine induced by Interferon-γ, and IP-10, the Interferon-γ-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997; 90: 4.099-4.105.
84. Felgar RE, Furth EE, Wasik MA, Gluckman SJ, Salhany KE. Histiocytic necrotizing lymphadenitis (Kikuchi's disease): in situ -labeling, immunohistochemical, and serologic evidence supporting cytotoxic lymphocyte-mediated apoptotic cell death. Mod Pathol 1997; 10: 231-241.
85. Moore KW, Rousset F, Banchereau J. Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1. Springer Semin Immunopathol 1991; 13: 157-166.
86. Aguado JM, Rodríguez JJ. Infecciones por el virus de Epstein-Barr: mononucleosis infecciosa, infecciones por virus herpes 6. En: Farreras P, Rozman C, editores. Barcelona: Mosby/Doyma Libros, 1995; 2.525-2.529.